We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
An adverse in utero experience negatively impacts perinatal growth in livestock. Maternal heat stress (HS) during gestation reduces placental growth and function. This progressive placental insufficiency ultimately leads to fetal growth restriction (FGR). Studies in chronically catheterized fetal sheep have shown that FGR fetuses exhibit hypoxemia, hypoglycemia, and lower anabolic hormone concentrations. Under hypoxic stress and nutrient deficiency, fetuses prioritize basal metabolic requirements over tissue accretion to support survival. Skeletal muscle is particularly vulnerable to HS-induced placental insufficiency due to its high energy demands and large contribution to total body mass. In FGR fetuses, skeletal muscle growth is reduced, evidenced by smaller myofiber size and mass, reduced satellite cell proliferation, and slower rate of protein synthesis. Disruptions in skeletal muscle growth are associated with mitochondrial dysfunction, including reduced pyruvate flux into the mitochondrial matrix and lower complex I activity in the mitochondrial electron transport chain. This review summarizes current research on the mechanisms by which HS-induced placental insufficiency affects skeletal muscle growth in the fetus, with an emphasis on myogenesis, hypertrophy, protein synthesis, and energy metabolism. The evidence presented is primarily drawn from experiments using chronically catheterized fetal sheep exposed to maternal HS during mid-gestation. Additionally, we explore emerging nutritional strategies aimed at enhancing skeletal muscle growth in animals with FGR. These strategies hold promise not only for improving reproductive efficiency in livestock affected by prenatal stress but also for their translational relevance to human pregnancies complicated by placental insufficiency.
Postpartum depression is prevalent among Black women and associated with intersecting systemic factors and interpersonal discrimination. However, gaps remain in understanding pregnancy-related changes in discrimination experiences that influence postpartum mental health and could inform preventive interventions. We hypothesized that young Black women would experience increasing levels of discrimination across the transition to parenthood, heightening depression risk relative to non-pregnant peers.
Methods
Participants comprised 335 Black primiparous women (ages 17-30 at delivery) and 335 age- and discriminationmatched non-pregnant controls from the Pittsburgh Girls Study. Self-reported discrimination experiences were collected at four timepoints: two years pre-pregnancy, one year pre-pregnancy, pregnancy, and one year postpartum for the childbearing sample, with corresponding data from the non-pregnant sample across the same interval (matched pairwise).
Results
Linear increases in discrimination were observed for the nonpregnant participants (BS = .480, SE = .090, p <.001), while childbearing participants showed no overall changes, though younger age predicted greater increases over time. For childbearing participants, both baseline discrimination (BI = .626, SE = .077, p < .001) and increasing discrimination (BS = 2.55, SE = .939, p < .01) predicted postpartum depressive symptoms, controlling for pre-pregnancy depression. Among non-pregnant participants, only baseline discrimination predicted later depression (BI = .912, SE = .081, p < .001).
Conclusions
Experiencing increasing levels of interpersonal discrimination across the transition to parenthood may heighten postpartum depression risk among young Black women, indicating a need for interventions supporting well-being and promoting resilience before, during and after pregnancy.
Using a behavioural intervention to target nutrition during pregnancy may be key in meeting recommendations for healthy eating. The aim was to assess the use of a short-term dietary intake measurement tool (3-day food intake record) to infer long-term habitual dietary intake during pregnancy (using a short-form food frequency questionnaire). A convenience sample (n=90) between 12- and 18-weeks’ gestation were recruited from a larger randomised controlled trial for cross-sectional analysis. Participants completed a 44-item food frequency questionnaire and 3-day food intake record. Using the participant food intake record, the investigator blindly completed a second frequency questionnaire. The frequency questionnaires were scored using Dietary Quality Scores (DQS) and compared. Aggregate data were evaluated using a Wilcoxon signed rank test, and individual-level data were evaluated using a Bland-Altman plot. No significant difference was observed in the scores (Z=-1.88, p=0.06), with small effect size (r=0.19). The Bland-Altman plot showed that comparing the DQS derived from the two different dietary assessments underestimated scores by a mean difference of 0.4 points (95% limits of agreement: -3.50 to 4.26). The data points were evenly spread suggesting no systematic variation for over- or underestimation of scores. Minimal difference was observed between the functionality of the two assessment instruments. However, the food intake record can be completed by pregnant individuals to estimate short-term nutrient intake, and then scored by the investigator to estimate long-term dietary quality. Combining these two instruments may best capture the most accurate representation of dietary habits over time.
Acute infection with Toxoplasma gondii in pregnant people can lead to vertical transmission to the foetus and congenital toxoplasmosis. As part of risk assessment, the epidemiology of toxoplasmosis among pregnant people must be quantitatively elucidated. Herein, we investigated the risk of primary T. gondii infection during pregnancy in Japan, estimating the incidence of T. gondii infection among pregnant people as well as that of congenital toxoplasmosis. We used a compartment model that captured the infection dynamics in pregnant people, analysing prescription data for spiramycin in Japan, together with local serological testing results and the screening rate of primary T. gondii infection during pregnancy. The nationwide risk of T. gondii infection pregnant people in Japan was estimated to be 0.016% per month. Among prefectures investigated, the risk estimate was highest in Tokyo with 0.030% per month. Nationally, the number of T. gondii infections among pregnant people in the years 2019, 2020, and 2021 was estimated to be 1507, 1440, and 1388 infections, respectively. The nationwide number of cases of congenital toxoplasmosis in each year was estimated at 613, 588, and 567 cases, respectively. Our study indicated that T. gondii infection continues to place a substantial burden on public health in Japan.
Edited by
Rebecca Leslie, Royal United Hospitals NHS Foundation Trust, Bath,Emily Johnson, Worcester Acute Hospitals NHS Trust, Worcester,Alex Goodwin, Royal United Hospitals NHS Foundation Trust, Bath,Samuel Nava, Severn Deanery, Bristol
Content on the physiology of pregnancy focuses on the commonly examined areas including the cardiovascular, respiratory, endocrine and haematological changes in pregnancy, then the subsequent impact upon conduct of anaesthesia. We include a section on the materno-fetal circulation and the placenta, with an emphasis on the changes that occur at birth.
Lamotrigine is beneficial in bipolar disorder and is often prescribed to patients during their period of reproductive potential. We summarise aspects of the pharmacology of lamotrigine, highlight its uses in psychiatric practice, drawing attention to recent findings relating to potential hazards arising from lamotrigine exposure in utero, and make some suggestions for clinical management.
During pregnancy, colonization by genital mycoplasmas may be associated with adverse outcomes. This study was conducted to investigate the prevalence of four species of Mollicutes (Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma parvum, and Ureaplasma urealyticum) in pregnant women receiving high-risk prenatal care and to evaluate possible associated factors. Data collection included the application of a questionnaire and the collection of cervical swabs from pregnant women. Species identification was performed by real-time PCR. The overall prevalence of Mollicutes was 60.97%. 55.9% of pregnant women were colonized by Ureaplasma spp., and 19.51% by Mycoplasma spp. The prevalence rates by species were 48.78% for U. parvum, 11.59% for U. urealyticum, 18.9% for M. hominis, and 1.22% for M. genitalium. Age, 12 years of schooling or more, age at first sexual intercourse up to 14 years, third trimester of pregnancy, having undergone infertility treatment, presence of STI, and groin lymph nodes were associated with a higher prevalence of microorganisms. The results presented are of utmost importance for understanding the prevalence of these microorganisms, the characteristics of colonized pregnant women, and planning screening strategies and interventions that minimize the negative impacts of these infections.
About 13% of pregnant women with substance use disorder (SUD) receive treatment and many may encounter challenges in accessing perinatal care, making it critical for this population to receive uninterrupted care during a global pandemic.
Methods
From October 2021-January 2022, we conducted an online survey of pregnant and postpartum women and interviews with clinicians who provide care to this population. The survey was administered to pregnant and postpartum women who used substances or received SUD treatment during the COVID-19 pandemic.
Results
Two hundred and ten respondents completed the survey. All respondents experienced pandemic-related barriers to routine health care services, including delays in prenatal care and SUD treatment. Disruptions in treatment were due to patient factors (38.2% canceled an appointment) and clinic factors (25.5% had a clinic cancel their appointment). Respondents were generally satisfied with telehealth (M = 3.97, SD = 0.82), though half preferred a combination of in-person and telehealth visits. Clinicians reported telehealth improved health care access for patients, however barriers were still observed.
Conclusions
Although strategies were employed to mitigate barriers in care during COVID-19, pregnant and postpartum women who used substances still experienced barriers in receiving consistent care. Telehealth may be a useful adjunct to enhance care access for pregnant and postpartum women during public health crises.
Tania starts her story with the dramatic description of her being prepared for ECT while pregnant. She has made an advance decision to have this treatment if she gets unwell during the pregnancy or after giving birth. Such a decision is also known as a Ulysses Pact. She wanted to get pregnant and knew that there was a strong risk of relapse of her bipolar disorder, which would make the pregnancy very risky. The story continues with the description of her life which was affected by episodes of illness that responded to ECT, and subsequent relapses. Over the last few years Tania has been on maintenance ECT and has had more than 200 sessions altogether. This did not prevent her from progressing into a very successful academic career. At one point she was at the Institute of Psychiatry in London, jointly leading a large research project on mental health advance directives, making her uniquely qualified to write on this topic.
Several dietary strategies are designed to achieve optimal glycaemic control in managing gestational diabetes mellitus (GDM), considering factors such as energy needs, the glycaemic index, high fibre content and the reduction or exclusion of sugary foods and drinks. However, in achieving therapeutic goals, there is a lack of consensus in the formulation of uniform recommendations. This article reviews the literature to assess the impact of dietary interventions on GDM risk – measured by the percentage of at-risk women who develop GDM – and on the progression of GDM pregnancies, including weight gain, hyperglycaemia severity, insulin requirements and perinatal outcomes such as macrosomia, hypertensive disorders, caesarean delivery and neonatal size. We conducted a thorough search of PubMed and the Cochrane Library, focusing on randomised controlled trials, cohort studies, systematic reviews and meta-analyses involving women either at risk of or diagnosed with GDM. These search criteria yielded 2800 articles, whose titles and abstracts were reviewed to determine their relevance to the research objective. In the initial search, 192 relevant articles met the inclusion criteria. The comprehensive analysis of these studies highlights the current uncertainty regarding the long-term consequences of recommended diets during pregnancy, especially among women with GDM. While the available literature is substantial, conclusions drawn from various methodologies and study populations have not yielded a consensus on the most effective diet for reducing perinatal complications. Nonetheless, it is reasonable to advocate for the early initiation of dietary interventions, particularly during pregnancy planning, especially among women exhibiting risk factors for GDM.
The purpose of this study was to report on the prevalence of hypertension and anaemia, and types of medications prescribed to expectant mothers attending antenatal clinics at Intermediate Hospital Katutura in Windhoek, Namibia.
Background:
Millennium Development Goals 4 and 5 speak to reduction of child mortality and improvement of maternal health by 2015, respectively. Gestational hypertension is a major contributor to maternal and perinatal mortality and is reported to affect up to 10% of women world-wide. Prevalence of anaemia among pregnant women is reported higher in low- and middle-income countries than in developed countries.
Methods:
This was a cross-sectional study involving the review of outpatient and clinic health records for patients attending antenatal clinics at Intermediate Hospital Katutura, Windhoek during October to November 2022. Data for patients on first antenatal clinic visit were obtained from facility antenatal clinic patient registers while that of follow-up patients were from patient health passports. All expectant mothers over 18 years of age who had provided written consent to participate, were included. Data collected were: age, body weight, haemoglobin concentration, blood pressure, gravida, number of babies delivered, pregnancy stage, comorbidities, and prescribed medications. The results were summarised using descriptive statistics. A p-value <0.05 is considered to be statistically significant.
Findings:
354 records were included: 303 (85.6%) first visit, and 51 follow-up (14.4%). There was a significant correlation between systolic blood pressure (BP) and body weight (r = 0.31, p < 0.001). 13.5% of first-time visitors had haemoglobin levels lower than the normal range (11 g/dL). Difference in haemoglobin levels between trimesters 1 and 3 were significant (p < 0.001). Methyldopa was prescribed for all hypertensive expectant mothers. To reduce the incidences of anaemia and hypertension during pregnancy, women of childbearing age should be encouraged to attend antenatal visits earlier in pregnancy and to take measures for body weight reduction, respectively.
This study aims to determine the factors associated with pregnant women’s perceived stress and coping styles after the devastating earthquake in Turkey.
Methods
This descriptive and cross-sectional study was conducted with 419 pregnant women between March 15 and May 15, 2023. Data were collected through the “Personal Information Form,” the “Perceived Stress Scale,” and the “Coping with Earthquake Stress Scale.”
Results
In this study, while the variables of employment status (P = 0.045) and number of pregnancies (P = 0.004) affected perceived stress, the variables of age (P = 0.049), income status (P = 0.003), place of residence (P = 0.036), and employment status (P = 0.001) were found to affect coping skills with earthquake stress. The Religious Coping sub-scale was a predictive factor on perceived stress (P = 0.002). In addition, a negative and linear relationship was found between the mean total score of the Perceived Stress Scale, the “Religious Coping” (P = 0.006, r = -0.134), “Positive Reappraisal” (P = 0.031, r = -0.106), and the total score of Coping with Earthquake Stress Scale (P = 0.005, r = -0.135).
Conclusions
This study found that there were some factors affecting the perceived stress and coping strategies of women after the earthquake, and the pregnant women used coping skills more as their perceived stress decreased; especially, they used religious coping and positive reappraisal strategies more.
In the absence of evidence-based therapeutic options for the majority of couples with recurrent pregnancy loss (RPL) it is considered significant to offer supportive care, including reliable counseling regarding the prognosis of subsequent pregnancies. Currently, various prediction models are available, with a focus on couples with unexplained RPL. All of them having drawbacks like substantial risk of bias, lack of performance measures and applicability. A new prediction model, using more predictors, such as male predictors and focusing on cumulative live birth rates over a reasonable time period is currently needed. In addition, this model should have the ability to provide reliable predictions at later time points, a so-called dynamic prediction model.
Gonococcal infection is the second most commonly reported bacterial infection. Untreated infection predisposes individuals to disseminated disease, which can result in dermatitis, tenosynovitis, migratory polyarthritis, or the “arthritis-dermatitis syndrome.” Disseminated gonococcal infection has a predilection for women and pregnancy is another risk factor. Suspect disseminated gonococcal infection in any sexually active woman (pregnant or otherwise) with septic arthritis. A history and physical examination usually lead to the working diagnosis; blood cultures, specimens from exposed mucosal surfaces, and affected synovial joint fluid aspirates help to confirm the diagnosis. Intravenous ceftriaxone is the mainstay of treatment, and complete resolution of symptoms without sequelae is the norm.
Hemoglobinopathies are vast grouping of inherited disorders of the hemoglobin chain genes that affect over 270 million people globally. The most common hemoglobinopathies include sickle cell, alpha- thalassemia, and beta-thalassemia. Each of these diseases has numerous phenotypes and thus presentation and management of each will vary. Generally, the carrier or asymptomatic states have pregnancy outcomes that mirror the general population. Patients with clinically significant disease are at increased risk for numerous maternal and fetal complications. All patients desiring pregnancy and those that are currently pregnant should be screened for hemoglobinopathy and those found to have one provided with genetic counseling regarding any potential maternal or fetal risks.
Fibroids are found in up to 10% of pregnant individuals and have been linked with multiple pregnancy complications. Most individuals will not experience fibroid-related pregnancy complications, but complications are more likely with larger and multiple fibroids. The risks of fibroids in pregnancy include preterm labor and delivery, fetal malpresentation, hemorrhage, and increased risk of cesarean delivery. Pregnant individuals should be counseled on these risks both during their antenatal care and upon admission to labor and delivery.
Hypothyroidism during pregnancy occurs when there is an increase in TSH levels. If the T4 levels are low, it is considered overt hypothyroidism; if the T4 levels are normal, it is subclinical hypothyroidism. The most common cause of hypothyroidism during pregnancy is Hashimoto’s disease, characterized by anti-thyroid peroxidase antibodies. Pregnant women with a history of thyroid disease, type 1 diabetes, or those experiencing symptoms such as fatigue, constipation, cold intolerance, dry skin, hair loss, and weight gain should be evaluated for thyroid disease. Uncontrolled hypothyroidism can lead to various complications such as spontaneous abortion, preterm birth, preeclampsia, abruptio placentae, stillbirth, low birth weight, and impaired neuropsychological development of the newborn. Treatment with levothyroxine (LT4) should be initiated when TSH levels are above 4 mU/L at a dose of 1–2 µg/kg/day or 100 µg/day. Adjust the dose every 4 weeks to maintain TSH concentrations at or below 2.5 mU/L. No additional fetal surveillance during pregnancy is recommended. If a patient is being treated for hypothyroidism, consider increasing the LT4 dose by 25% upon pregnancy confirmation. During postpartum, decrease LT4 to pre-pregnancy level. If LT4 was started during pregnancy, maintain the exact dosage to prevent the disease progression and support lactation.
The workup of urolithiasis during pregnancy often requires a multidisciplinary approach. This case examines the physical and anatomical changes in pregnancy that can lead to urolithiasis and the pathophysiology of the disease. Through a patient case, the physical findings, laboratory tests, and imaging studies needed to establish a diagnosis of urolithiasis in pregnancy is reviewed. Treatment options for urolithiasis and special considerations in the pregnant population are then discussed in detail, covering both conservative management and invasive procedures. Specific guidance is provided as to when additional imaging tests or consultation with interventional radiology or urology is warranted.